These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31849091)

  • 1. Hodgkin lymphoma in a bone marrow aspirate.
    Parsons K; Leach M; Bain BJ
    Am J Hematol; 2020 Mar; 95(3):328-329. PubMed ID: 31849091
    [No Abstract]   [Full Text] [Related]  

  • 2. Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevance.
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Eur J Haematol; 2015 Jul; 95(1):83-9. PubMed ID: 25537478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change of initial staging at early remission evaluation with FDG-PET/CT in Hodgkin lymphoma: a report of two cases.
    Molin D; Hagberg H; Suurküla M; Aström G
    Acta Oncol; 2010 May; 49(4):526-8. PubMed ID: 20397779
    [No Abstract]   [Full Text] [Related]  

  • 4. Limited role of bone marrow biopsy for detection of marrow involvement in patients with Hodgkin lymphoma from the Middle East and North Africa region.
    Damlaj M; Gmati G; Syed G; Pasha T; Salama H; Ali O; Abuelgasim KA; Al-Zahrani M; Al Askar A; Alhejazi A
    Hematol Oncol Stem Cell Ther; 2018 Jun; 11(2):114-117. PubMed ID: 29079127
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients.
    Chen-Liang TH; Martin-Santos T; Jerez A; Senent L; Orero MT; Remigia MJ; Muiña B; Romera M; Fernandez-Muñoz H; Raya JM; Fernandez-Gonzalez M; Lancharro A; Villegas C; Carlos Herrera J; Frutos L; Luis Navarro J; Uña J; Igua C; Sanchez-Vaño R; Cozar Mdel P; Contreras J; Sanchez-Blanco JJ; Perez-Ceballos E; Ortuño FJ
    Am J Hematol; 2015 Aug; 90(8):686-90. PubMed ID: 25925613
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Hassan A; Siddique M; Bashir H; Riaz S; Wali R; Mahreen A; Nawaz MK
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1198-1206. PubMed ID: 28229191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary?
    Adams HJ; Kwee TC; de Keizer B; Fijnheer R; de Klerk JM; Littooij AS; Nievelstein RA
    Ann Oncol; 2014 May; 25(5):921-7. PubMed ID: 24351400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?
    Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
    Nucl Med Commun; 2016 Jan; 37(1):23-9. PubMed ID: 26440567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of a graft-versus-Hodgkin lymphoma effect in the setting of extensive bone marrow involvement.
    Anderlini P; Swanston N; Rashid A; Bueso-Ramos C; Macapinlac HA; Champlin RE
    Biol Blood Marrow Transplant; 2008 Apr; 14(4):478-80. PubMed ID: 18342791
    [No Abstract]   [Full Text] [Related]  

  • 10. Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma.
    El-Galaly TC; d'Amore F; Mylam KJ; de Nully Brown P; Bøgsted M; Bukh A; Specht L; Loft A; Iyer V; Hjorthaug K; Nielsen AL; Christiansen I; Madsen C; Johnsen HE; Hutchings M
    J Clin Oncol; 2012 Dec; 30(36):4508-14. PubMed ID: 23150698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Numerous Reed-Sternberg cells in bone marrow aspirate from a patient with the syncytial variant of nodular sclerosis classical Hodgkin lymphoma.
    Lee SG; Paik SY; Sohn HJ; Kim SY; Kong SY
    Int J Hematol; 2015 Feb; 101(2):107-8. PubMed ID: 25552247
    [No Abstract]   [Full Text] [Related]  

  • 12. Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma?
    Çetin G; Çıkrıkçıoğlu MA; Özkan T; Karatoprak C; Ar MC; Eşkazan AE; Ayer M; Cerit A; Gözübenli K; Uysal BB; Erdem S; Ergül N; Tatar G; Çermik TF
    Turk J Haematol; 2015 Sep; 32(3):213-9. PubMed ID: 25912844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study.
    Pelosi E; Penna D; Douroukas A; Bellò M; Amati A; Arena V; Passera R; Bisi G
    Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):469-75. PubMed ID: 21150862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match?
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Ann Nucl Med; 2015 Feb; 29(2):132-7. PubMed ID: 25348549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study.
    Zwarthoed C; El-Galaly TC; Canepari M; Ouvrier MJ; Viotti J; Ettaiche M; Viviani S; Rigacci L; Trentin L; Rusconi C; Luminari S; Cantonetti M; Bolis S; Borra A; Darcourt J; Salvi F; Subocz E; Tajer J; Kulikowski W; Malkowski B; Zaucha JM; Gallamini A
    J Nucl Med; 2017 Aug; 58(8):1249-1254. PubMed ID: 28126883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hodgkin lymphoma infiltration with associated haemophagocytosis in bone marrow films.
    Demagny J; Guiheneuf E; Joris M; Garçon L; Harrivel V
    Br J Haematol; 2019 Oct; 187(2):138. PubMed ID: 31355912
    [No Abstract]   [Full Text] [Related]  

  • 17. Bone marrow trephine biopsy in Hodgkin's lymphoma. Comparison with PET-CT scan in 65 patients.
    Lakhwani S; Cabello-García D; Allende-Riera A; Cárdenas-Negro C; Raya JM; Hernández-Garcia MT
    Med Clin (Barc); 2018 Feb; 150(3):104-106. PubMed ID: 28864087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can fluorodeoxyglucose positron emission tomography/computed tomography avoid negative iliac crest biopsies in evaluation of marrow involvement by lymphoma at time of initial staging?
    Mittal BR; Manohar K; Malhotra P; Das R; Kashyap R; Bhattacharya A; Varma N; Varma S
    Leuk Lymphoma; 2011 Nov; 52(11):2111-6. PubMed ID: 21745169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of classic Hodgkin lymphoma on bone marrow biopsy.
    Laurent C; Arber DA; Johnston P; Fend F; Zamo A; Attygalle AD
    Histopathology; 2020 Jun; 76(7):934-941. PubMed ID: 32092168
    [No Abstract]   [Full Text] [Related]  

  • 20. Loss of utility of bone marrow biopsy as a staging evaluation for Hodgkin lymphoma in the positron emission tomography-computed tomography era: a West of Scotland study.
    Hamilton R; Andrews I; McKay P; Leach M
    Leuk Lymphoma; 2014 May; 55(5):1049-52. PubMed ID: 23915196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.